Close Menu

Microarrays Inc.

Microarrays Inc. is now offering custom laboratory services for gene expression projects.

New Product Watch: Oct 25, 2011

Premium

Microarrays Inc. this week launched three MI PathArray assays for studying targeted biological pathways. The new arrays cover pathways associated with apoptosis, growth factors, and inflammation.

The Huntsville, Ala.-based firm has tapped Cambio to distribute its products in the UK and Ireland; BioCat to cover Germany, Austria, and Switzerland; and Biosolutions to sell its arrays to customers in Cyprus, Greece, and other Balkan countries.

People in the News: Feb 8, 2011

Premium

Erik Holmlin, Edward Erickson, Andrew Jennings

The new corporate structure will allow Microarrays to "quickly and nimbly" respond to the growing needs of customers, especially in the diagnostics and healthcare markets, the company said in a statement.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.